Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Jul;34(7):1815–1818. doi: 10.1128/jcm.34.7.1815-1818.1996

Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic.

C M Chu 1, C T Yeh 1, C T Chiu 1, I S Sheen 1, Y F Liaw 1
PMCID: PMC229124  PMID: 8784599

Abstract

By using an amplification-created restriction site method, the precore TAG mutant of hepatitis B virus was detected in 6 (75%) of 8 acute fulminant hepatitis B patients, 7 (58%) of 12 acute self-limiting hepatitis B patients, 35 (81%) of 43 hepatitis B virus surface antigen carriers with fulminant hepatitis, and 42 (70%) of 60 hepatitis B virus surface antigen carriers with chronic hepatitis. The precore TAG mutant prevails in acute and chronic hepatitis B of various severity in this area where hepatitis B is endemic.

Full Text

The Full Text of this article is available as a PDF (199.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aye T. T., Uchida T., Becker S. O., Hirashima M., Shikata T., Komine F., Moriyama M., Arakawa Y., Mima S., Mizokami M. Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B. Dig Dis Sci. 1994 Jun;39(6):1281–1287. doi: 10.1007/BF02093794. [DOI] [PubMed] [Google Scholar]
  2. Brunetto M. R., Giarin M. M., Oliveri F., Chiaberge E., Baldi M., Alfarano A., Serra A., Saracco G., Verme G., Will H. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4186–4190. doi: 10.1073/pnas.88.10.4186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carman W. F., Fagan E. A., Hadziyannis S., Karayiannis P., Tassopoulos N. C., Williams R., Thomas H. C. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology. 1991 Aug;14(2):219–222. [PubMed] [Google Scholar]
  4. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9;2(8663):588–591. doi: 10.1016/s0140-6736(89)90713-7. [DOI] [PubMed] [Google Scholar]
  5. Chu C. M., Karayiannis P., Fowler M. J., Monjardino J., Liaw Y. F., Thomas H. C. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology. 1985 May-Jun;5(3):431–434. doi: 10.1002/hep.1840050315. [DOI] [PubMed] [Google Scholar]
  6. Chu C. M., Liaw Y. F., Pao C. C., Huang M. J. The etiology of acute hepatitis superimposed upon previously unrecognized asymptomatic HBsAg carriers. Hepatology. 1989 Mar;9(3):452–456. doi: 10.1002/hep.1840090319. [DOI] [PubMed] [Google Scholar]
  7. Chu C. M., Liaw Y. F. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection. 1990 Jul-Aug;18(4):200–203. doi: 10.1007/BF01643385. [DOI] [PubMed] [Google Scholar]
  8. Chu C. M., Sheen I. S., Liaw Y. F. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 1994 Jul;107(1):189–195. doi: 10.1016/0016-5085(94)90076-0. [DOI] [PubMed] [Google Scholar]
  9. Eiken H. G., Odland E., Boman H., Skjelkvåle L., Engebretsen L. F., Apold J. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res. 1991 Apr 11;19(7):1427–1430. doi: 10.1093/nar/19.7.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Féray C., Gigou M., Samuel D., Bernuau J., Bismuth H., Bréchot C. Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol. 1993 Apr;18(1):119–122. doi: 10.1016/s0168-8278(05)80019-4. [DOI] [PubMed] [Google Scholar]
  11. Günther S., Meisel H., Reip A., Miska S., Krüger D. H., Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology. 1992 Mar;187(1):271–279. doi: 10.1016/0042-6822(92)90315-g. [DOI] [PubMed] [Google Scholar]
  12. Hsu H. Y., Chang M. H., Lee C. Y., Hsieh K. H., Ni Y. H., Chen P. J., Chen D. S. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis. 1995 Apr;171(4):776–781. doi: 10.1093/infdis/171.4.776. [DOI] [PubMed] [Google Scholar]
  13. Kosaka Y., Takase K., Kojima M., Shimizu M., Inoue K., Yoshiba M., Tanaka S., Akahane Y., Okamoto H., Tsuda F. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology. 1991 Apr;100(4):1087–1094. doi: 10.1016/0016-5085(91)90286-t. [DOI] [PubMed] [Google Scholar]
  14. Laskus T., Persing D. H., Nowicki M. J., Mosley J. W., Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology. 1993 Oct;105(4):1173–1178. doi: 10.1016/0016-5085(93)90964-e. [DOI] [PubMed] [Google Scholar]
  15. Liang T. J., Hasegawa K., Rimon N., Wands J. R., Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 1991 Jun 13;324(24):1705–1709. doi: 10.1056/NEJM199106133242405. [DOI] [PubMed] [Google Scholar]
  16. Liaw Y. F., Pao C. C., Chu C. M. Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis. Liver. 1988 Aug;8(4):231–235. doi: 10.1111/j.1600-0676.1988.tb00998.x. [DOI] [PubMed] [Google Scholar]
  17. Okamoto H., Yotsumoto S., Akahane Y., Yamanaka T., Miyazaki Y., Sugai Y., Tsuda F., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990 Mar;64(3):1298–1303. doi: 10.1128/jvi.64.3.1298-1303.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Omata M., Ehata T., Yokosuka O., Hosoda K., Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991 Jun 13;324(24):1699–1704. doi: 10.1056/NEJM199106133242404. [DOI] [PubMed] [Google Scholar]
  19. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Trepo C. G., Robert D., Motin J., Trepo D., Sepetjian M., Prince A. M. Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Gut. 1976 Jan;17(1):10–13. doi: 10.1136/gut.17.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Woolf I. L., El Sheikh N., Cullens H., Lee W. M., Eddleston A. L., Williams R., Zuckerman A. J. Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Br Med J. 1976 Sep 18;2(6037):669–671. doi: 10.1136/bmj.2.6037.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yeh C. T., Chiu C. T., Tsai S. L., Hong S. T., Chu C. M., Liaw Y. F. Absence of precore stop mutant in chronic dual (B and C) and triple (B, C, and D) hepatitis virus infection. J Infect Dis. 1994 Dec;170(6):1582–1585. doi: 10.1093/infdis/170.6.1582. [DOI] [PubMed] [Google Scholar]
  23. Yotsumoto S., Kojima M., Shoji I., Yamamoto K., Okamoto H., Mishiro S. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. Hepatology. 1992 Jul;16(1):31–35. doi: 10.1002/hep.1840160107. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES